Stem Cells from Hair Follicles May Help "Grow" New Blood Vessels
BUFFALO, N.Y. -- For a rich source of stem cells to be engineered
into new blood vessels or skin tissue, clinicians may one day look no
further than the hair on their patients' heads, according to new
research published earlier this month by University at Buffalo
engineers. "Engineering blood vessels for bypass surgery,
promoting the formation of new blood vessels or regenerating new skin
tissue using stem cells obtained from the most accessible source --
hair follicles -- is a real possibility," said Stelios T. Andreadis,
Ph.D., co-author of the paper in Cardiovascular Research and
associate professor in the Department of Chemical and Biological
Engineering in the UB School of Engineering and Applied Sciences. Researchers from other institutions previously had shown that hair follicles contain stem cells.
In the current paper, the UB researchers demonstrate that stem cells
isolated from sheep hair follicles contain the smooth muscle cells that
grow new vasculature. The group recently produced data showing that
stem cells from human hair follicles also differentiate into
contractile smooth muscle cells. "We have demonstrated that
engineered blood vessels prepared with smooth muscle progenitor cells
from hair follicles are capable of dilating and constricting, critical
properties that make them ideal for engineering cardiovascular tissue
regeneration," said Andreadis. In addition to growing new skin
for burn victims, cells from hair follicles could potentially be used
to engineer vascular grafts and possibly regenerate cardiac tissues for
patients with heart problems. Since smooth muscle cells
comprise the muscle of numerous tissues and organs, including the
bladder, abdominal cavity and gastrointestinal and respiratory tracts,
this new, accessible source of cells may make possible future
treatments that allow for the regeneration of these damaged organs as
well. Andreadis and his colleagues previously engineered
functional and implantable blood vessels with smooth muscle and
endothelial cells originating from bone-marrow mesenchymal stem cells. A key advantage of mesenchymal cells is that they typically do not trigger an immune reaction when transplanted, he said.
"Preliminary experiments in our laboratory suggest an exciting
possibility -- that stem cells from hair follicles may be similar to
bone-marrow mesenchymal cells," Andreadis said. "The best case
scenario is that from this one very accessible and highly proliferative
source of stem cells, we will be able to obtain multiple different cell
types that can be used for a broad range of applications in
regenerative medicine," he said.
Go Back to Other News Stories
|